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Abstract 
 
Fibroblast growth factors (FGFs) have been shown to control formation and differentiation of 
multiple organ systems in the developing vertebrate embryo. The analysis of differential gene 
expression during embryogenesis is therefore a potent tool to identify novel target genes 
regulated by FGF signalling. Here, we have applied microarray analysis to identify 
differentially regulated genes in FGF mutant mouse embryos. Surprisingly, transcripts 
corresponding to vomeronasal receptors (VRs), which so far have been only detected in the 
vomeronasal organ (VNO), were found to be downregulated in FGF mutant embryos. VR 
expression was detected in the developing olfactory pit and the anlage of the VNO. 
Interestingly, several FGFs can be detected in the developing olfactory pit during mouse 
embryogenesis (Bachler and Neubüser, 2001). FGF signalling may thus control expression of 
VRs in the olfactory pit and formation of the VNO. Moreover, VR expression was detected in 
unexpected locations within the developing embryo including retina, dorsal root ganglia and 
neural tube. The relevance of VR expression in these structures and for formation of the VNO 
is discussed. 
 
 
 
Introduction 
Fibroblast growth factors (FGFs) make up a family of polypeptide growth factors found 
throughout the animal kingdom. During embryonic development, they regulate cell 
proliferation and differentiation, body plan formation and organogenesis (Ornitz and Itoh, 
2001; Reuss and von Bohlen und Halbach., 2003). Several FGF members, among them FGF3, 
FGF8, FGF10 and FGF19, have been implicated in different stages of inner ear development 
(Barald and Kelley, 2004; Ladher et al., 2005). The stage of the otic vesicle (otocyst) is of 
high importance for inner ear development, because at this time point the inner ear undergoes 
subdivision into defined compartments, ultimately leading to the generation of the highly 
complex differentiated organ (Brigande et al., 2000). This process of regionalization and 
specification is very likely to be regulated by different genetic pathways. Indeed, previous 
studies, based on a cDNA subtraction screening technique, have identified numerous 
candidate genes potentially involved in controlling patterning of the inner ear at the otocyst 
stage (Powles et al., 2004). Recently, it was shown that FGF3 and FGF10 synergistically 
control formation of the otic vesicle in mice (Alvarez et al., 2003; Wright and Mansour, 
2003). Since next to the inner ear, FGF3 and FGF10 have been shown to control the 
formation of other embryonic structures, including lung, limbs and tail (Mansour et al., 1993; 
Min et al., 1998; Sekine et al., 1999) during mouse development, mouse mutants for these 
FGF genes may serve as an ideal tool to identify novel downstream effectors of FGF 
signaling.  
The vomeronasal organ (VNO) originates from the medial wall of the olfactory (nasal) pit 
where the VNO anlage is induced as a bud which will form the vomeronasal groove (Garrosa 
et al., 1998). In adult mammals, the mature VNO located in the nasal septum contains sensory 
neurons, which project their axons to the accessory olfactory bulb (AOB). In turn, neurons of 
the AOB project to discrete loci within the vomeronasal amygdala (Halpern, 1987). After 
direct contact with pheromone sources, these non-volatile chemicals enter the VNO and elicit 
complex behavioral responses. It is believed that the pheromone molecules are bound by 
vomeronasal receptors (VRs) from the multigene family of G-protein-coupled receptors, 
which trigger a phospholipase C (PLC)-dependent signal cascade (Holy et al., 2000). The 
mature VNO is organized into two distinct layers. Vomeronasal receptor neurons with cell 
bodies in the apical part of the sensory epithelium express the G-protein α-subunit Gαi2 and 
project to the anterior part of the AOB, whereas basally located neurons of the VNO express 
the G-protein α-subunit Goα and project to the posterior region of the AOB (Berghard and 
Buck, 1996, Jia et al., 1997, Shinohara et al., 1992). In addition, apical neurons express 
receptors of the V1R family, whereas basal sensory neurons express those of the V2R family. 
Each of these VR multigene families comprises more than a hundred genes (Dulac and 
Torello, 2003), thereby adding significant complexity to the analysis of individual VR genes. 
Recently, it was shown that small peptides which serve as ligands for major 
histocompatibility complex (MHC) class I molecules can stimulate V2R receptors (Leinders-
Zufall et al., 2004).  
In the present report we have used microarrays to screen for novel targets of FGF signaling by 
hybridising them with cDNAs derived from FGF3, FGF10 and homozygous compound 
mutants for these genes. As expected we found genes normally expressed in the otic vesicle to 
be downregulated in FGF mutants. Unexpectedly however, we also found transcripts derived 
from the V2R gene family to be downregulated in these mutants. Expression of V2R 
transcripts was detected in the olfactory pit, retina, dorsal root ganglia (DRG) and neural tube 
of mouse embryos. FGFs thus appear to control early expression of V2Rs in the developing 
embryo. These results suggest potential roles of FGF signaling during formation of the VNO 
and other embryonic structures expressing V2R transcripts. 
 
Results 
 
A microarray-based screen for FGF-regulated genes 
FGF3 and FGF10 have been shown to control formation of the otic vesicle in mice (Alvarez 
et al., 2003; Wright and Mansour, 2003). Double mutant homozygous Fgf3-/-/Fgf10 -/-embryos 
lack otic vesicles or only form microvesicles at the otic vesicle stage from embryonic day 9 
(E9) to E10. To reveal the genes regulated by FGF signaling during embryogenesis we 
employed gene chips covering the expression of 36.000 known mouse genes and expressed 
sequence tags (U74ABC V.2 set from Affymetrix; see methods). Due to the very limited 
amount of otic tissue in Fgf3 -/-/Fgf10-/- mutants we opted to isolate RNA from embryonic 
tissue at E10 corresponding to the area of the otic vesicle and neighbouring tissue, including 
periotic mesenchyme and the neural tube (see methods). Both of the latter tissues have been 
shown to be essential for formation of the inner ear and influence the expression of otic genes 
(Baker and Bronner-Fraser, 2001). In our analysis, we compared three groups of embryos 
against their wild-type littermates: Fgf3-/-, Fgf10-/-, and double Fgf3 -/-/Fgf10-/- mutants (see 
methods). As a result, a list of genes, which showed altered expression levels in the absence 
of FGFs, was generated. We discovered genes already reported to have expression in the otic 
vesicle, as well as genes not previously implicated during inner ear development (see below). 
We further focused our analysis on a set of selected genes downregulated in the FGF-deficient 
embryos, as presented in Figure 1. These genes corresponded to retinaldehyde-dehydrogenase 
1 (Aldh1 (Raldh1); Romand et al., 2004), chromobox homolog 3 (Cbx3; Jones et al., 2001), 
myeloblastosis oncogene-like 1  (Mybl1; Trauth et al., 1994), otoconin 90 (Oc90 (Oc95); 
Wang et al., 1998; Verpy et al., 1999) and vomeronasal receptors (V2Rs; Herrada and Dulac, 
1997; Matsunami and Buck; 1997; Ryba and Tirindelli; 1997). A complete list of the 
microarray results obtained from the hybridizations of the U74A V.2 chips can be found in 
the supplementary information. 
To analyse more globally in the developing embryo the differential expression of the selected 
genes with an independent technique, we next employed semi-quantitative reverse-
transcriptase polymerase chain reaction (RT-PCR). We extracted total RNA from wild-type, 
Fgf3-/-, Fgf10-/- and Fgf3-/-/Fgf10-/- embryos at E10, which then served as a template in a one-
step RT-PCR with gene-specific primers (see methods). RNA amounts in samples were 
normalized by using two independent housekeeping genes, beta-actin and glyceraldehyde 3-
phosphate dehydrogenase (gapdh). Among the genes we analyzed by RT-PCR, we found 
Aldh1  and V2Rs to be downregulated in single and compound FGF mutants (Fig.2 A, C), 
while Oc90 was only downregulated in Fgf3 -/-/Fgf10 -/- double mutants (Fig. 2 B), consistent 
with the results from the gene chips (Fig.1). In contrast, Cbx3 and Mybl1 failed to show a 
significant change in mRNA levels between wild-type and FGF mutant embryos (data now 
shown).  
 
Downregulation of vomeronasal receptors in FGF mutant embryos 
 
Surprisingly, some of the most strongly FGF-regulated genes turned out to be transcripts 
corresponding to vomeronasal receptor genes. So far, expression of vomeronasal receptors 
has been reported only in the vomeronasal organ (VNO), which is part of the vomeronasal 
system responsible for the molecular detection of pheromone signals (Dulac and Torello, 
2003). Two large families of genes encoding pheromone receptors (V1Rs and V2Rs) have 
been described (Dulac and Axel; 1995; Herrada and Dulac, 1997; Matsunami and Buck; 
1997; Ryba and Tirindelli; 1997). Initially, we detected several members of the V2R family 
(V2R1, V2R2, V2R8, V2R9, V2R12) downregulated on the gene chips (See Figure 1 and data 
not shown). In contrast, all genes of the V1R family which were represented on the gene chips 
displayed no significant changes (data not shown). At a closer look, we discovered that all 
oligos used on the Murine Genome U74A Chip representing the V2R family, were selected 
from a 450-bp stretch that bore 100% to 98,5% identity between the V2R genes. Therefore, 
expression of even a single V2R gene from this group would produce a positive signal for all 
of them. It was thus unclear, whether indeed only a single or a subset of V2R genes were 
differentially expressed. Therefore, we refer to the differentially regulated vomeronasal 
receptors as “V2Rs”, indicating the possibility of multiple gene products. To clarify the 
identity of V2R transcripts, we subcloned the V2R RT-PCR products amplified from total 
RNA from E10 embryos. Importantly, in the RT-PCRs we observed a single discrete band 
corresponding to the expected size of 417 nucleotides of the RT-PCR fragment amplified 
from V2Rs using primers whose sequences were conserved between the V2Rs found to be 
differentially expressed (Fig. 2C). Bacteria were transformed with a mix of plasmids bearing 
the PCR products as an insert, and individual clones were subjected to sequencing. After 
processing twenty clones we discovered that either of two V2Rs were present, highly 
homologous V2R8 and V2R9. Therefore it appears likely that at least some of the V2R 
transcripts found to be differentially expressed in FGF mutants are derived from the V2R8 
and V2R9 genes, which both belong to the family B of V2R receptors (Yang et al., 2005). 
 
Embryonic expression pattern of V2R-related transcripts  
 
To examine the spatial expression pattern of V2R genes in the developing embryo, we 
generated an in situ probe from the 450 bp nucleotide sequence corresponding to V2Rs on the 
gene chip and analyzed the expression pattern on E8.5-E12 mouse embryos using RNA in situ 
hybridization and optical projection tomography (OPT; see methods). V2R expression was 
observed between E10-E12 in various parts of the developing embryo, including dorsal root 
ganglia (DRGs), neural tube, retina and olfactory pit (Fig. 3B-G). In DRGs, intense V2R 
expression was observed at E10 but was found to be downregulated at E12 (Fig. 3B,C and 
data not shown). In the olfactory pit, V2R expression was initially observed in the lateral wall 
at E10 (Fig. 3E). At E11.75 V2Rs maintained this expression domain, but additionally 
transcripts were detected in the vomeronasal anlage which forms and starts to invaginate in 
the medial part of the olfactory pit (Fig. 3F,G). 
To reconfirm the presence and differential expression of V2Rs in these novel and unexpected 
sites in the developing embryo we isolated RNA from DRGs, which can be easily isolated 
from E12 onwards (see methods). We thus prepared DRGs from E13 wild-type and Fgf10-/- 
mutants and performed RT-PCR using V2R primers. We could confirm presence of the V2R 
transcript and its downregulation in DRGs from Fgf10-/- mutants compared with the wild-type 
(Fig. 2D). We were further interested to define if DRGs indeed expressed V2R8 transcripts as 
suggested by the sequence analysis of the V2R transcripts amplified by PCR (see above). 
Using gene-specific primers, we could confirm presence of V2R8 transcripts in DRGs and 
their downregulation in Fgf10-/- mutants (Fig. 2E).  
 
Development of the vomeronasal organ in FGF mutants  
 
To determine if V2R8(V2R)-downregulation by FGF signaling leads to any defects in the 
VNO, we examined the phenotype of the VNO in FGF mutants. Since FGF10 mutants die at 
birth we chose Fgf3-/- and compound Fgf3-/-/Fgf10+/- mutants for histological analysis of the 
VNOs. No abnormalities in organ morphology or neuronal appearance were detected at E18 
and in adult animals (Figure 4A,B and data not shown). The number of basally located 
neurons expressing V2R genes was also normal, as confirmed by immunohistochemical 
staining with an antibody against V2R2, which was previously shown to label all basal VNO 
neurons (Fig. 4C,D; Martini et al., 2001). At the molecular level, we did not observe any 
decrease in V2R8 gene levels by RT-PCR in adult VNO RNA from Fgf3-deficient mice as 
well as compound Fgf3-/-/Fgf10+/- mutants (data not shown). These results were also 
confirmed with the V2R primers, directed against various family members of the V2R gene 
family. Likewise, male-male aggression (resident-intruder test) and mating behavior 
controlled by the VNO showed no apparent changes in Fgf3-deficient mice (data not shown). 
Slightly less efficient mating in compound Fgf3 -/-/Fgf10+/- mutants was attributed to their 
idiopathic weight reduction and smaller size. Therefore, downregulation of V2R transcripts in 
FGF mutant embryos appears not to affect morphology or functionality of the VNO. 
 
Discussion 
Downregulation of otic genes in FGF mutants 
Next to the unexpected finding of V2R downregulation in FGF mutant embryos, the loss of 
two genes known to be expressed in the inner ear could also be confirmed. Otoconin-90/95 is 
the major component of otoconia of the inner ear (Wang et al., 1998; Verpy et al., 1999). 
Importantly, otoconin-90 is exclusively expressed in the otic vesicle at E10 (Verpy et al., 
1999), which underscores the achievement of one of our aims to identify genes specific to the 
otic vesicle altered in FGF mutants during embryogenesis. In the case of otoconin-90/95 the 
downregulation is only observed in Fgf3-/-/Fgf10-/- double mutants which is most likely 
explained by the severe loss of otic tissue in these mutants at E10 (Alvarez et al., 2003; 
Wright and Mansour, 2003). 
Expression of Raldh1 has been described in the dorsal-medial part of the otic vesicle which 
gives rise to the endolymphatic duct and parts of the vestibular system (Haselbeck et al., 
1999; Romand et al., 2004). Loss of the endolymphatic duct and defects in the vestibular 
system have been described in a FGF3 mouse mutant (Mansour et al., 1993) and/or FGF10 
mouse mutants (Pauley et al., 2003; Ohuchi et al., 2005), indicating that Raldh1 may 
participate in the morphogenesis of these inner ear structures. However, no inner ear 
phenotypes have been reported so far in Raldh1 knockout mice (Fan et al., 2003).  
 
 
Does loss of FGF signaling affect formation of the VNO? 
In the present report we have detected V2R transcripts in several structures of the developing 
mouse embryo and found these transcripts to be downregulated in FGF mutant embryos. Is 
there a link between FGF signaling, expression of V2R transcripts and formation of the 
VNO? In mice, the VNO develops from a thickening within the olfactory pit at around E11 
(Cuschieri and Bannister, 1975). Interestingly, we observed expression of V2R transcripts 
within the olfactory pit between E10 and E12. At this timepoint the expression of several 
FGFs, including FGF3 and FGF10 have also been described in the olfactory pit (Bachler and 
Neubüser, 2001). Notably at E10, FGF3 expression is present in the medial part of the 
olfactory pit where the VNO anlage will form and where V2R expression is detected at 
E11.75. On the other hand, FGF10 expression overlaps with V2R expression in the lateral 
part of the olfactory pit at E10. Therefore, a combinatorial expression pattern of FGFs may be 
important to control V2R expression in the olfactory pit during development. We have 
obtained no evidence for molecular or morphological changes in the mature VNO of FGF 
mouse mutants. A possible explanation for this may be the presence of redundant pathways of 
FGF signaling controlling V2R expression and formation of the VNO. Consistent with this 
hypothesis mouse mutants for FGFR1, a high-affinity receptor for FGF3 and FGF10, show 
defects during development of the VNO (A. Neubüser, personal communication). It will 
therefore be interesting to further elucidate which FGF ligands participate in VNO formation 
and how they control V2R expression. One of the key factors for VNO formation may be 
FGF8 which is highly expressed in the olfactory pit (Bachler and Neubuser, 2001) and has 
been shown to control facial morphogenesis most likely via the expression of several 
downstream targets, possibly also including members of the retinaldehyde dehydrogenase 
enzyme family (Trumpp et al., 1999; Finberg and Neubüser, 2002; Song et al., 2004; see also 
above). Preliminary studies of mouse mutants homozygous for FGF3 and heterozygous for 
FGF8 (Fgf3-/-/Fgf8+/-) show a severe loss of aggressive behaviour between adult males in the 
resident-intruder test, consistent with a defect in the VNO (M. T. Alonso and T. Schimmang, 
unpublished results). Therefore, further studies of these mutants may reveal important insights 
in the role of FGF signaling for formation and functional differentiation of the VNO. 
 
Is there are molecular basis for V2R signaling during embryonic development? 
 
In the present article we have described V2R expression in a number of unexpected sites in 
the developing embryo, including the retina, neural tube and DRGs. V2R receptors 
functionally associate with MHC I molecules and β2-microglobulin and are coupled to Goα 
proteins (Berghard and Buck, 1996; Loconto et al., 2003; Dulac and Torello, 2003). It is 
noteworthy that both MHC I molecules and β2-microglobulin are expressed in the developing 
embryo (Jaffe et al., 1990; Jaffe et al., 1991), including DRGs (Neumann et al., 1997). Our 
preliminary analysis of Goα expression in the developing mouse has also revealed presence of 
Goα transcripts in the DRGs and neural tube (O. Lioubinski, unpublished observation). 
Therefore, certain signaling components of the cascade triggered by V2R receptors may 
indeed be present during embryonic development. V2Rs may thus perform as yet unknown 
cellular functions in neural structures outside of the VNO. Interestingly, MHC I molecules 
which can associate with V2Rs have been shown to control neuronal differentiation and 
plasticity during development (Boulanger and Shatz, 2004). Therefore, V2Rs may also 
transiently participate in control of neural functions during embryonic development. Further 
studies will be required to clarify the potential role of V2Rs during embryogenesis outside the 
VNO. 
 
 
 
 
Experimental Procedures 
CHIP hybridizations 
RNA was prepared from otic vesicles and neighbouring tissues, including the neural tube and 
periotic mesenchyme of embryos at E10 (see Fig. 3A). Two independent RNA samples were 
obtained from a total of ten embryos of each of the following genotypes: wild-type, Fgf3-/-, 
Fgf10 -/- and Fgf3-/-/Fgf10-/- mutants. RNA preparation, hybridization to oligonucleotide arrays 
(U74ABC, version 2) and scanning of the arrays was performed as described in the 
Affymetrix GeneChip Expression Analysis Manual (http://www.affymetrix.com). Scanned 
files were analyzed with GeneChip (Affymetrix) and the expression data were saved as an 
Excel file containing expression values (Average Difference). Results from the hybridisations 
of U74A V.2 microarrays can be found in the supplementary information and at ArrayExpress 
(http://www.ebi.ac.uk/arrayexpress/) under accession number E-MEXP-430. 
Semi-quantitative RT-PCR 
For semi-quantitative RT-PCR, RNA was extracted from whole embryos or dorsal root 
ganglia with TRIZOL reagent (Invitrogen), digested in solution with DNaseI (Roche), and 
purified with RNAeasyKit, including a second DNaseI digestion step (on-column). Absence 
of genomic DNA contamination was confirmed by RT-PCR with primers against mouse pdx-
1 gene. For this, the forward primer was chosen from the exonic, and the reverse in the 
intronic region. A 150-bp band would be produced only in case of genomic DNA traces in the 
sample. Following these steps, RNA was used as template for RT-PCR (Qiagen OneStep RT-
PCR Kit). RNA was diluted such that the intensity of the beta-actin PCR product bands of all 
RNA samples was equal at their earliest visible cycle. RNA calibration was then confirmed 
by RT-PCR with primers against another housekeeping gene, glyceraldehyde 3-phosphate 
dehydrogenase (gapdh). After calibration, RT-PCRs with gene-specific primers were 
performed simultaneously with RT-PCR for beta-actin. Aliquots of PCR mixes were removed 
at multiple points in the cycles, applied on an agarose gel, and DNA bands were visualized by 
ethidium bromide. Band intensities were compared to each other at the lowest number of 
cycles at which products started to be visible. The following primers were used (all sequences 
from mus musculus): beta-actin (Genebank accession Nr. NM_007393): forward 5’-
TGTGATGGTGGGAATGGGTCAG-3’, reverse 5’-TTTGATGTCACGCACGATTTCC-3’, 
Aldh1  (NM_013467): fw 5’-CTGGGCTGACAAGATTCATGGTCA-3’, rev 5’-
GGTGAAGAGCCGTGAGAGGAGTTT-3’, Cbx3 (NM_007624): fw 5’-
ATGCTGATAATACTTGGGAACCAG-3’, rev 5’-
GTAGAAGGCAATGACAATCTGAGG-3’, Mybl1 (NM_008651): fw 5’-
ctcatggatgatagtatgtctaaca-3’, rev 5’-GGATGTTAAAGGAATAGCTTCACTG, Oc90 
(NM_010953): fw 5’-CTGCTGTTTGGAGCAGATGAGACAA-3’, rev. 5’-
TCCGTCTGGTGACTTGAGGCTTTGA-3’, Pdx1 (NM_039324): fw 5’-
CCAGTGGGCAGGTAAGCCT-3’, rev 5’-TCCTAGCCTCGATTATCCTTGC-3’, V2R 
(multiple sequences): fw 5’-GTTGCTAATGTGTATCTTTGTCCCA-3’, rev 5’-
TCATGTCCATTGTGTATGCAGTACC-3’, V2R8 (NM_009494): fw 5’-
CTCCTCCGTGTGTAGTGTGG-5’, rev 5’-GCTGAGAATGCGGTTATTGG-3’, (V2R9 
(NM_009495): fw 5’-CAGACATGAAGAAGCTCTGTGC-3’, rev 5’-
GGATTCCTGTTGATCTCATCG-3’.) 
 
RNA in situ hybridization analysis 
RNA whole-mount in situ hybridization was essentially performed as described by Conlon 
and Rossant (Conlon and Rossant, 1992) using digoxigenin-labelled riboprobes, which were 
detected by alkaline phosphatase-coupled antibodies. For histological examination, embryos 
were postfixed in 4% PFA, embedded in gelatin and sectioned at 30 µm on a vibratome. For 
whole-mount RNA in situ hybridization a V2R2 antisense-riboprobe corresponding to 
nucleotides 2416 to 2832 of the V2R2 cDNA (accession number AF011412) was used. 
Optical Projection Tomography (OPT) 
After RNA in situ hybridsation  embryos were fixed overnight (o/n) in 4% PFA at 4oC, rinsed 
briefly in destilled water and embedded in pre-warmed low melting agarose (1% in water). 
Once the agarose had solidified at room temperature (RT), blocks were cut and dehyrated in 
methanol at RT o/n. After dehydration of the agarose blocks, specimens were cleared in 
BABB (Benzyl alcohol/ Benzyl benzoate, 1:2) for one or two days. The specimens were 
scanned with an OPT Scanner (provided by the MRC Human Genetics Unit, Edinburgh). 
Scans were performed in a bright field channel using 700 or 750 nm filters. The 3D 
reconstructions were performed as described by Sharpe et al. (2002). Images of virtual 
sections shown here were captured directly from the 3D reconstructions. 
 
Isolation of dorsal root ganglia 
Dorsal root ganglia from embryos were isolated as described by Kleitmann et al., (1998). 
 
Histology and Immunohistochemistry 
For light microscopy, adult mice were anesthetized with ketamine sulphate and transcardially 
perfused with 4% paraformaldehyde in phosphate buffer. The noses were removed and left in 
10% EDTA solution for decalcification. Afterwards, pieces were processed for paraffin 
embedding. Sectioning of paraffin blocks was carried out with a Minot microtome at 7 µm 
and sections were stained with hematoxylin and eosin. Immunohistochemistry on adult VNOs 
using V2R2 antibodies was performed as described by Martini et al. (2001). 
 
Acknowledgements  
This work is dedicated to María Gómez Gómez. We thank Annette Neubüser, Sybille Köhnke 
and Michaela Miehe for communicating unpublished results, help in genotyping mice and 
analyzing results of the microarrays, respectively. V2R2-antibodies and Fgf10-/- mutants were 
a generous gift from Roberto Tirindelli and Shigeaki Kato, respectively. This work has been 
generously supported by Deutsche Forschungsgemeinschaft (SFB444) and grant BFU2004-
00860 of the Spanish MEC. 
 
Literature 
Alvarez, Y., Alonso, M.T., Vendrell, V., Zelarayan, L.C., Chamero, P., Theil, T., Bösl, M.R., 
Kato, S., Maconochie, M., Riethmacher, D., Schimmang, T. 2003. Requirements for FGF3 
and FGF10 during inner ear formation. Development 130, 6329-6338.  
Bachler, M., Neubuser, A. 2001. Expression of members of the Fgf family and their receptors 
during midfacial development. Mech. Dev. 100, 313-316. 
Baker, C.V., Bronner-Fraser, M. 2001. Vertebrate cranial placodes I. Embryonic induction. 
Dev. Biol. 232, 1-61.  
Barald, K.F., Kelley, M.W. 2004. From placode to polarization: new tunes in inner ear 
development. Development. 131, 4119-4130.  
Berghard, A., Buck, L.B. 1996. Sensory transduction in vomeronasal neurons: Evidence for g 
alpha o, g alpha i2, and adenylyl cyclase II as major components of a pheromone signaling 
cascade. J. Neurosci. 16, 909-918. 
Boulanger, L.M., Shatz, C.J. Immune signalling in neural development, synaptic plasticity 
and disease. Nat. Rev. Neurosci. 5, 521-531.  
Brigande, J.V., Kiernan, A.E., Gao, X., Iten, L.E., Fekete, D.M. 2000. Molecular genetics of 
pattern formation in the inner ear: do compartment boundaries play a role? Proc. Natl. Acad. 
Sci. USA. 97, 11700-11706. 
Conlon, R.A., Rossant, J. 1992. Exogenous retinoic acid rapidly induces anterior ectopic 
expression of murine Hox-2 genes in vivo. Development. 116, 357-368.  
Cuschieri, A., Bannister, L.H. 1975. The development of the olfactory mucosa in the mouse: 
Light microscopy. J. Anat. 119, 277-286. 
Dulac, C., Axel, R. 1995. A novel family of genes encoding putative pheromone receptors in 
mammals. Cell 83, 195-206 
Dulac, C. and Torello, A.T. 2003. Molecular detection of pheromone signals in mammals: 
From genes to behaviour. Nat. Rev. Neurosci. 4, 551-562. 
Fan, X., Molotkov, A., Manabe, S., Donmoyer, C.M., Deltour, L., Foglio, M.H., Cuenca, 
A.E., Blaner, W.S., Lipton, S.A., Duester, G. 2003. Targeted disruption of Aldh1a1 (Raldh1) 
provides evidence for a complex mechanism of retinoic acid synthesis in the developing 
retina. Mol. Cell. Biol. 23, 4637-4648 
Firnberg, N., Neubuser, A. 2002. FGF signaling regulates expression of Tbx2, Erm, Pea3, and 
Pax3 in the early nasal region. Dev. Biol. 247, 237-250. 
Garrosa, M., Gayoso, M.J., Esteban, F.J. 1998. Prenatal development of the mammalian 
vomeronasal organ. Microscopy Res. Tech. 41, 456-470. 
Halpern, M. 1987. The organization and function of the vomeronasal system. Annu. Rev. 
Neurosci. 10, 325-362. 
Haselbeck, R.J., Hoffmann, I., Duester, G. 1999. Distinct functions for Aldh1 and Raldh2 in 
the control of ligand production for embryonic retinoid signaling pathways. Dev. Genet. 25, 
353-364. 
Herrada, G., Dulac, C. 1997. A novel family of putative pheromone receptors in mammals 
with a topographically organized and sexually dimorphic distribution. Cell 90, 763-773. 
Holy, T.E., Dulac, C., Meister, M. 2000. Responses of vomeronasal neurons to natural 
stimuli. Science 289, 1569-1572. 
Jaffe, L., Jeannotte, L., Bikoff, E.K., Robertson, E.J. 1990. Analysis of beta 2-microglobulin 
gene expression in the developing mouse embryo and placenta. J. Immunol. 145, 3474-3482. 
Jaffe, L., Robertson, E.J., Bikoff, E.K. 1991. Distinct patterns of expression of MHC class I 
and beta 2-microglobulin transcripts at early stages of mouse development. J. Immunol. 147, 
2740-2749. 
Jia, C., Goldman, G., Halpern, M. 1997. Development of vomeronasal receptor neuron 
subclasses and establishment of topographic projections to the accessory olfactory bulb. Brain 
Res. Dev. Brain Res. 102, 209-216. 
Jones, DO., Mattei, M.G., Horsley, D., Cowell, I.G., Singh, P.B. 2001. The gene and 
pseudogenes of Cbx3/mHP1 gamma. DNA Seq. 12, 147-160. 
Kleitmann, N., Wood, P.M., Bunge, R.P. 1998. Tissue culture methods for the study of 
myelination in culturing nerve cells in Banker, G and Goslin, K. (Eds.), Culturing Nerve 
Cells, MIT press, pp. 545-594. 
Ladher, R.K., Wright, T.J., Moon, A.M., Mansour, S.L., Schoenwolf, G.C. 2005. FGF8 
initiates inner ear induction in chick and mouse. Genes Dev. 19, 603-613.  
Leinders-Zufall, T., Brennan, P., Widmayer, P., Prashanth Chandramani, S., Maul-Pavicic, 
A., Jager, M., Li, X.H., Breer, H., Zufall, F., Boehm, T. 2004. MHC class I peptides as 
chemosensory signals in the vomeronasal organ. Science 306, 1033-1037. 
Loconto, J., Papes, F., Chang, E., Stowers, L., Jones, E.P., Takada, T., Kumanovics, A., 
Fischer Lindahl, K., Dulac, C. 2003. Functional expression of murine V2R pheromone 
receptors involves selective association with the M10 and M1 families of MHC class Ib 
molecules. Cell 112, 607-618. 
Mansour, S.L., Goddard, J.M., Capecchi, M.R. 1992. Mice homozygous for a targeted 
disruption of the proto-oncogene int-2 have developmental defects in the tail and inner ear. 
Development. 117, 13-28. 
Martini, S., Silvotti, L., Shirazi, A., Ryba, N.J. and Tirindelli, R. 2001. Co-expression of 
putative pheromone receptors in the sensory neurons of the vomeronasal organ. J. Neurosci. 
21, 843-848. 
Matsunami, H., Buck, L.B. 1997. A multigene family encoding a diverse array of putative 
pheromone receptors in mammals. Cell 90, 775-784. 
Min, H., Danilenko, D.M., Scully, S.A., Bolon, B., Ring, B.D., Tarpley, J.E., DeRose, M., 
Simonet, W.S. 1998. Fgf-10 is required for both limb and lung development and exhibits 
striking functional similarity to Drosophila branchless. Genes Dev. 12, 3156-3161. 
Neumann, H., Schmidt, H., Wilharm, E., Behrens, L., Wekerle, H. 1997. Interferon gamma 
gene expression in sensory neurons: evidence for autocrine gene regulation. J. Exp. Med. 186, 
2023-2031. 
Ohuchi, H., Yasue, A., Ono, K., Sasaoka, S., Tomonari, S., Takagi, A., Itakura, M., 
Moriyama, K., Noji, S., Nohno, T. 2005. Identification of cis-element regulating expression 
of the mouse Fgf10 gene during inner ear development. Dev. Dyn. 233, 177-187. 
Ornitz, D.M., Itoh, N. 2001. Fibroblast growth factors. Genome Biol. 2 (3):REVIEWS3005.  
Pauley, S., Wright, T.J., Pirvola, U., Ornitz, D., Beisel, K., Fritzsch, B. 2003. Expression and 
function of FGF10 in mammalian inner ear development. Dev. Dyn. 227, 203-215.  
Powles, N., Babbs, C., Ficker, M., Schimmang, T. and Maconochie, M. 2004. Identification 
and analysis of genes from the mouse otic vesicle and their association with developmental 
subprocesses through in situ hybridization. Dev. Biol. 268, 24-38. 
Reuss, B., von Bohlen und Halbach, O. 2003. Fibroblast growth factors and their receptors in 
the central nervous system. Cell Tissue Res. 313, 139-157.  
Romand, R., Niederreither, K., Abu-Abed, S., Petkovich, M., Fraulob, V., Hashino, E., Dolle, 
P. 2004. Complementary expression patterns of retinoid acid-synthesizing and -metabolizing 
enzymes in pre-natal mouse inner ear structures. Gene Expr. Patterns 4, 123-133.  
Ryba, N.J., Tirindelli, R. 1997. A new multigene family of putative pheromone receptors. 
Neuron 19, 371-379. 
Sekine, K., Ohuchi, H., Fujiwara, M., Yamasaki, M., Yoshizawa, T., Sato, T., Yagishita, N., 
Matsui, D., Koga, Y., Itoh, N., Kato, S. 1999. Fgf10 is essential for limb and lung formation. 
Nat. Genet. 21, 138-141. 
Sharpe, J., Ahlgren, U., Perry, P., Hill, B., Ross, A., Hecksher-Sorensen, J., Baldock, R., 
Davidson, D. 2002. Optical projection tomography as a tool for 3D microscopy and gene 
expression studies. Science. 296, 541-545 
Shinohara, H., Asano, T. and Kato, K. 1992. Differential localization of g-proteins gi and go 
in the accessory olfactory bulb of the rat. J. Neurosci. 12, 1275-1279. 
Song, Y., Hui, J.N., Fu, K.K., Richman, J.M. 2004. Control of retinoic acid synthesis and 
FGF expression in the nasal pit is required to pattern the craniofacial skeleton. Dev. Biol. 276, 
313-329. 
Trauth, K., Mutschler, B., Jenkins, N.A., Gilbert, D.J., Copeland N.G., Klempnauer, K.H. 
1994. Mouse A-myb encodes a trans-activator and is expressed in mitotically active cells of 
the developing central nervous system, adult testis and B lymphocytes. EMBO J. 13, 5994-
6005. 
Trumpp, A., Depew, M.J., Rubenstein, J.L., Bishop, J.M., Martin, G.R. 1999. Cre-mediated 
gene inactivation demonstrates that FGF8 is required for cell survival and patterning of the 
first branchial arch. Genes Dev. 13, 3136-3148.  
Verpy, E., Leibovici, M., Petit, C. 1999. Characterization of otoconin-95, the major protein of 
murine otoconia, provides insights into the formation of these inner ear biominerals. Proc. 
Natl. Acad. Sci. U S A. 96, 529-534.  
Wang, Y., Kowalski, P.E., Thalmann, I., Ornitz, D.M., Mager, D.L., Thalmann, R. 1998. 
Otoconin-90, the mammalian otoconial matrix protein, contains two domains of homology to 
secretory phospholipase A2. Proc. Natl. Acad. Sci. USA 95,15345-15350. 
Wright, T.J., Mansour, S.L. 2003. Fgf3 and Fgf10 are required for mouse otic placode 
induction. Development. 130, 3379-3390. 
Yang, H., Shi, P., Zhang, Y., Zhang, J. 2005. Composition and evolution of the V2r 
vomeronasal receptor gene repertoire in mice and rats. Genomics 86, 306-315. 
 
Figure Legends 
Figure 1 
Selected genes, downregulated in Fgf3-/-, Fgf10 -/- and compound Fgf3-/-/Fgf10-/- mouse mutant 
embryos compared to wild-type embryos at E10. Signal fold changes showing fold-down-
regulation between wild-type and mutant samples are indicated.  
 
Figure 2 
Downregulation of retinaldehyde-dehydrogenase1, otoconin 90 and vomeronasal receptors 
(V2Rs) in FGF mutants. Using primers for the indicated genes semi-quantitative RT-PCR was 
performed from RNA isolated from whole embryos at E10 (A-C) and dorsal root ganglia at 
E13 (D,E) from embryos with the indicated genotypes. Abbreviations: wt, wild-type; ko3, 
Fgf3-/- mutant; ko10, Fgf10 -/- mutant; dko, Fgf3 -/-/Fgf10 -/- mutant. 
 
Figure 3 
Expression of vomeronasal recptors (V2Rs) in mouse embryos (A) Embryo at E10 in which 
the otic vesicle (asterisk) and the area used for the preparation of RNA for the hybridisation of 
the microarrays are indicated. (B) Dorsal view of an embryo at E10 showing presence of V2R 
transcripts in the neural tube (nt) and dorsal root ganglia (drg). (C) Horizontal section 
showing expression of V2Rs in the dorsal part of the neural tube (nt) and dorsal root ganglia 
(drg) at E10. (D) Section through the developing eye at E10 showing expression of V2R in 
the retina (r). (E) Coronal section showing expression of V2Rs in the lateral part of the 
olfactory pit (op) at E10. (F) Coronal OPT section showing expression in the lateral part of 
the nasal pit (left) and the anlage of the VNO (asterisks) at E11.75. (G) 3D reconstruction of 
the expression domains of V2R in the nasal pit at E11.75. The medial (m) -lateral (l) axis and 
the anlage of the VNO is indicated by an asterisk. 
 
Figure 4 
Morphology of the vomeronasal organ (VNO) in adult Fgf3 -/- mouse mutants. Coronal 
sections through the VNO of an adult wild-type (wt) mouse (A,C) and a Fgf3 -/- knock-out (ko) 
mutant (B,D). (A,B) Note the presence of a normally structured VNO in the mutant. (C,D) 
Coronal sections of the VNO stained with V2R2 antibodies marking vomeronasal receptor 
neurons in the basal part of the neuroepithelium, characterized by the expression of V2Rs and 
the G-protein α-subunit Goα. Abbreviations: l, lumen; ns non-sensory epithelium; se, sensory 
epithelium. 
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